Literature DB >> 32522559

COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?

Benedicte Caron1, Yves Arondel2, Jean-Marie Reimund3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32522559     DOI： 10.1016/j.cgh.2020.06.002

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  2 in total

1.  Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2?

Authors:  Bilger Çavuş; Filiz Akyüz; Aslı Örmeci Çifçibaşı; İlker Özgür; Cansu Erel; Aysun Yakut; Ziya İmanov; İbrahim Volkan Şenkal; Alpay Medetalibeyoğlu; Murat Köse; Metin Keskin; Kadir Demir; Fatih Beşışık; Sabahattin Kaymakoğlu
Journal:  Turk J Gastroenterol       Date:  2022-03       Impact factor: 1.555

Review 2.  COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges.

Authors:  Iolanda Valentina Popa; Mircea Diculescu; Cătălina Mihai; Cristina Cijevschi-Prelipcean; Alexandru Burlacu
Journal:  Gastroenterol Res Pract       Date:  2020-07-10       Impact factor: 2.260
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.